NEWS
September 28, 2023
ARMIS BIOPHARMA® Announces Receipt of a $20.3 Million Contract with the Defense Threat Reduction Agency to Develop Veriox® DECON for Battlefield Wounds
Read More HereMay 31, 2023
Armis Biopharma® Announces 510(k) Clearance for VeriCyn® Wound Wash
Read More HereDecember 14, 2022
VERIOX® DECON IS SHOWN TO KILL BIOLOGICAL WARFARE AGENT, ANTHRAX
Read More HereSeptember 15, 2022
Armis Biopharma® Announces Release of Phase 2 Grant Award from the National Institutes of Health
Read More HereSeptember 22, 2021
ARMIS BIOPHARMA® DONATES ARMICLENZ® TO CONVOY OF HOPE FOR HURRICANE IDA VICTIMS
Read More HereNovember 19, 2020
Armis Biopharma® Announces 510(k) Clearance for VeriFixxTM Small Bone Implant
Read More HereSeptember 9, 2020
ARMIS BIOPHARMA® Announces Grant Award from the National Institutes of Health
Read More Here